--- title: Dr. John Baldoni, Advisor | Biospring Partners description: Dr. John Baldoni advises Biospring Partners after 29 years leading R&D at GSK, where he held senior executive roles across drug discovery and development. --- [![Biospring Partners logo](https://biospring.com/hubfs/darkLogo.svg)](https://biospring.com/) - [Home](https://biospring.com) - [The Firm](https://biospring.com/the-firm) - [Team](https://biospring.com/team) - [Portfolio](https://biospring.com/portfolio) - [News and Insights](https://biospring.com/biospring-news) - [Contact Us](https://biospring.com/contact-us) - [LP Login](https://www.fundpanel.io/Login) [![Biospring Partners logo](https://biospring.com/hubfs/darkLogo.svg)](https://biospring.com/) ![Menu](https://biospring.com/hubfs/raw_assets/public/Biospring/Images/mobile-menu-bars-black.svg) - [Home](https://biospring.com) - [The Firm](https://biospring.com/the-firm) - [Team](https://biospring.com/team) - [Portfolio](https://biospring.com/portfolio) - [News and Insights](https://biospring.com/biospring-news) - [Contact Us](https://biospring.com/contact-us) - [LP Login](https://www.fundpanel.io/Login) [Full Biospring Team](https://biospring.com/team) ![Dr. John Baldoni, Former EVP R&D, GSK](https://biospring.com/hs-fs/hubfs/Dr.%20John%20Baldoni.jpg?width=604&height=526&name=Dr.%20John%20Baldoni.jpg) # Dr. John Baldoni ### Former EVP R&D, GSK John is the Chief Technology Officer of Integral. He has over 39 years of experience in the pharmaceutical industry—29 years at GSK R&D including 11 years on its executive leadership team. John has participated in the research and development of scores of commercial products. John’s most recent roles before Integral were SVP of GSK’s science and technology platforms and SVP of a small in silico drug discovery unit. John is a proponent of seeking, integrating and implementing innovative approaches to drug discovery and development. He led several GSK innovation initiatives through internal teams, technology acquisitions and partnerships. John conceptualized and is currently senior science advisor to the Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium – an open membership, public/private partnership currently comprised of Pharma, Tech, Lawrence Livermore National Laboratory, Frederick National Laboratory for Cancer Research, and the University of California, San Francisco. John is also Chair of the Executive Committee of the Alliance for Artificial Intelligence in Healthcare, an organization formed to foster improved healthcare by responsible investment, invention and innovation in artificial intelligence. John received his PhD from Penn State University in biological chemistry. ## Other Advisory Board Members - [![Sir John Bell, Former Regius Chair of Medicine, University of Oxford](https://biospring.com/hs-fs/hubfs/Sir%20John%20Bell.png?width=604&height=526&name=Sir%20John%20Bell.png)](https://biospring.com/sir-john-bell) #### Sir John Bell Regius Professor of Medicine at Oxford University [Read Bio](https://biospring.com/sir-john-bell) - [![Dr. David Mauney, Former Managing Director, Koch Disruptive Technologies](https://biospring.com/hs-fs/hubfs/David%20Final.png?width=604&height=526&name=David%20Final.png)](https://biospring.com/david-mauney) #### Dr. David Mauney Former Managing Director, Koch Disruptive Technologies [Read Bio](https://biospring.com/david-mauney) - [![Dr. John Ludwig, Former Senior Vice President of Pharmaceutical Sciences and Global Clinical Supply at Pfizer R&D](https://biospring.com/hs-fs/hubfs/John%20Ludwig.jpg?width=604&height=526&name=John%20Ludwig.jpg)](https://biospring.com/dr-john-d.-ludwig) #### Dr. John Ludwig Former Senior Vice President of Pharmaceutical Sciences and Global Clinical Supply at Pfizer R&D [Read Bio](https://biospring.com/dr-john-d.-ludwig) - [![Bob Pozen, Former Chair, MFS; Former President, Fidelity Investments](https://biospring.com/hs-fs/hubfs/Bob%20Pozen.jpg?width=604&height=526&name=Bob%20Pozen.jpg)](https://biospring.com/bob-pozen) #### Bob Pozen Senior Fellow at the Brookings Institution [Read Bio](https://biospring.com/bob-pozen) - [![Qi Wang, CIO, Portfolio Implementation, PIMCO](https://biospring.com/hs-fs/hubfs/Qi%20Wang.jpg?width=604&height=526&name=Qi%20Wang.jpg)](https://biospring.com/qi-wang) #### Qi Wang CIO, Portfolio Implementation, PIMCO [Read Bio](https://biospring.com/qi-wang) - [![Dr. Peter Henry, Senior Fellow, Hoover Institution](https://biospring.com/hs-fs/hubfs/Dr.%20Peter%20Henry.jpg?width=604&height=526&name=Dr.%20Peter%20Henry.jpg)](https://biospring.com/peter-henry) #### Dr. Peter Henry Senior Fellow, Hoover Institution [Read Bio](https://biospring.com/peter-henry) - [![Dr. John Sexton, President Emeritus, New York University](https://biospring.com/hs-fs/hubfs/Dr.%20John%20Sexton.jpg?width=604&height=526&name=Dr.%20John%20Sexton.jpg)](https://biospring.com/john-sexton) #### Dr. John Sexton President Emeritus, New York University [Read Bio](https://biospring.com/john-sexton) - [Home](https://biospring.com) - [The Firm](https://biospring.com/the-firm) - [Team](https://biospring.com/team) - [Portfolio](https://biospring.com/portfolio) - [News & Insights](https://biospring.com/biospring-news) - [Contact Us](https://biospring.com/contact-us) - [LP Login](https://www.fundpanel.io/Login) ### Newsletter [Privacy Policy](https://biospring.com/privacy-policy) | ©2026 All Rights Reserved Biospring ![](https://biospring.com/hubfs/raw_assets/public/Biospring/Images/footerWatermark.svg) ![Biospring Partners logo](https://biospring.com/hubfs/whiteLogo.svg)